Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

被引:0
|
作者
Elalfy, Mohsen Saleh [1 ]
Hassan, Tamer [2 ]
Elsayh, Khalid [3 ]
Maebid, Mohamed [4 ]
Hassab, Hoda [5 ,6 ]
Elashry, Rasha [7 ]
El Ghamrawy, Mona [8 ]
Elhawy, Mahmoud [9 ]
Zakaria, Marwa [10 ]
Elshanshory, Mohamed [11 ]
机构
[1] Ain Shams Univ, Cairo, Egypt
[2] Zagazig Univ, Zagazig, Egypt
[3] Assiut Univ, Assiut, Egypt
[4] Bany Soif Univ, Bany Soif, Egypt
[5] Alexandria Univ, Paediat Dept, Fac Med, Alexandria, Egypt
[6] Alexandria Univ, Clin Res Ctr, Fac Med, Alexandria, Egypt
[7] Mansoura Univ, Mansoura, Egypt
[8] Cairo Univ, Cairo, Egypt
[9] Menoufia Univ, Menoufia, Egypt
[10] Zagazig Univ, Zagazig, Egypt
[11] Tanta Univ, Tanta, Egypt
关键词
D O I
10.1182/blood-2019-121994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4907
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Modeling Clinical Practice Guidelines for Interactive Decision Support Exemplified by Primary Myelofibrosis and Immune Thrombocytopenia
    Philipp, Patrick
    Hempel, Louisa
    Hempel, Dirk
    Beyerer, Juergen
    2021 INTERNATIONAL CONFERENCE ON COMPUTATIONAL SCIENCE AND COMPUTATIONAL INTELLIGENCE (CSCI 2021), 2021, : 1163 - 1168
  • [32] FINAL RESULTS FROM AN OBSERVATIONAL STUDY (PLATEAU) OF ADULT PATIENTS TREATED WITH ROMIPLOSTIM FOR PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ROUTINE CLINICAL PRACTICE IN GERMANY
    Reiser, M.
    Welslau, M.
    Josten, K.
    Dietzfelbinger, H.
    Kuhn, A.
    HAEMATOLOGICA, 2017, 102 : 591 - 592
  • [33] TREATMENT OF ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WITH ROMIPLOSTIM IN ROUTINE CLINICAL PRACTICE IN GERMANY-INTERIM RESULTS FROM AN OBSERVATIONAL STUDY (PLATEAU)
    Welslau, M.
    Reiser, M.
    Illmer, T.
    Josten, K.
    Dietzfelbinger, H.
    Seitz, A.
    HAEMATOLOGICA, 2014, 99 : 204 - 204
  • [34] MULTI-CENTER, PROSPECTIVE STUDY TO EVALUATE THE EFFICACY OF "BIWEEKLY" ROMIPLOSTIM IN ADULT IMMUNE THROMBOCYTOPENIA (ITP); PROLONGED DOSE INTERVAL ≥2 WEEKS IS NOT RECOMMENDABLE
    Park, S.
    Lee, J. H.
    Park, J. S.
    Lee, J. W.
    Jang, J. H.
    HAEMATOLOGICA, 2015, 100 : 567 - 568
  • [36] REDUCED HOSPITALIZATIONS AND BLEEDS IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) RECEIVING ROMIPLOSTIM IN CLINICAL PRACTICE - INTERIM RESULTS FROM A LARGE, EUROPEAN, OBSERVATIONAL STUDY
    Steurer, M.
    Janssens, A.
    Selleslag, D.
    Wadenvik, H.
    Quittet, P.
    Kaiafa, G.
    Kozak, T.
    Papadaki, H.
    Viallard, J.
    Belton, L.
    Kreuzbauer, G.
    HAEMATOLOGICA, 2013, 98 : 194 - 195
  • [37] Levothyroxine poisoning in children is usually benign: A multi-center experience from Turkey
    Sen Kucuk, Kubra
    Demir, Sule
    Sevim, Reyhan Deveci
    Akgul, Fatma
    Yalcin, Gulsen
    Eser, Oznur
    Bal, Alkan
    Ergun, Elif
    Ozturk, Sercan
    Anik, Ahmet
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 468 - 468
  • [38] Efficiency and Safety of Eltrombopag for Multi-Line Failed Chinese Patients with Immune Thrombocytopenia: Cases with Decreased Megakaryocyte Response Well from Single Center Experience
    Liu, Qi
    Shen, Yingying
    Li, Yuzhu
    Hu, Huijing
    Liu, Wenbin
    Zhao, Yuechao
    Dong, Huijie
    Shen, Yiping
    Zhou, Yuhong
    Ye, Baodong
    Wu, Dijiong
    BLOOD, 2021, 138
  • [39] Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience
    Liu, Qi
    Shen, Yingying
    Li, Yuzhu
    Hu, Huijin
    Liu, Wenbin
    Zhao, Yuechao
    Dong, Huijie
    Shen, Yiping
    Zhou, Yuhong
    Ye, Baodong
    Wu, Dijiong
    IMMUNOLOGIC RESEARCH, 2022, 70 (01) : 67 - 74
  • [40] Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience
    Qi Liu
    Yingying Shen
    Yuzhu Li
    Huijin Hu
    Wenbin Liu
    Yuechao Zhao
    Huijie Dong
    Yiping Shen
    Yuhong Zhou
    Baodong Ye
    Dijiong Wu
    Immunologic Research, 2022, 70 : 67 - 74